TUimpact SoSe25 SMFormate14 Kopie

TU.impact

Hack the norm.
Make space for HER.

Werde Teil des Female Empowerment Programms der TU Wien und unterstütze Schülerinnen auf ihrem Bildungsweg.

Warum mitmachen?

  • Soft-Skill-Workshops: Kommunikation, interkulturelle Kompetenz, emotionale Intelligenz, Problemlösung.
  • Generationsübergreifendes Mentoring
  • Vorbildfunktion: Zeige Schülerinnen, wie spannend technische Bildungswege sind.
  • Erfahrungen erfolgreicher Role Models: Lerne von erfolgreichen Frauen aus der Wirtschaft.
  • Das Programm ist eine offizielle Lehrveranstaltung mit 3 ECTS in den Transferable Skills der TU Wien.
Female Role Models 2025
Diese Termine sind für das Sommersemester 2025 relevant:
Alle Termine
Hier findest du alle wichtigen Infos zum Programm:
FAQs
Alle Infos zu den Partnerunternehmen:
Unternehmensinfos
TUimpact SoSe25 mitLogos
You have not accepted to load Youtube videos from third parties
Cookie Consent Settings Open video in new window

Any questions?

Tina

Mag. Tina Landreau
tina.landreau@tucareer.com

LinkedIn

kennen.lernen

Robert Bosch AG

Work #LikeABosch

Read more
Schiebel Elektronische Geräte

High-Tech Company and Global Market Leader: The Schiebel Group specialises in the development and production of high-tech mine detection equipment and the unmanned high-tech helicopter system CAMCOPTER® S-100 UAS (Unmanned Aerial System).

Read more
Leobersdorfer Maschinenfabrik GmbH

For 175 years, Leobersdorfer Maschinenfabrik (LMF) has been a symbol of innovation, reliability, and technical excellence. As a leading manufacturer of high pressure compressor solutions, LMF in Leobersdorf develops and produces customized solutions for a sustainable energy future. Whether in hydrogen, biomethane, oil & gas, or the chemical industry – LMF sets global standards and delivers reliable solutions that meet the highest international requirements.

Read more
Octapharma Pharmazeutika

For more than 40 years, Octapharma has grown into the world's largest privately owned and independent plasma fractionator, with more than 11,000 dedicated employees manufacturing high-quality, life-saving medicines derived from human plasma and human cell lines. Every day, we work to support the treatment of patients in 120 countries and, in doing so, improve their lives. Our efforts focus on three therapeutic areas: immunotherapy, hematology, and critical care. Octapharma operates seven research and development sites, five production facilities in Austria, France, Germany, and Sweden, as well as over 190 plasma donation centers across Europe and the United States. Vienna is home to Octapharma’s largest production site, covering the entire value chain from R&D and production to support functions. More than 1,500 employees from 37 nations work at the Vienna site.

Read more
We use cookies and similar technologies to provide certain features, enhance the user experience and deliver content that is relevant to your interests. Depending on their purpose, analysis and marketing cookies may be used in addition to technically necessary cookies. By clicking on "Agree and continue", you declare your consent to the use of the aforementioned cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy.